Model Evaluation

Keeping training and test data separate allows evaluation to focus on observations not used to develop the model. This provides evidence about performance on data relevant to the intended purpose rather than only performance during development. In medical research, that distinction helps determine whether predictions are dependable enough to support further investigation or clinical decision-making.

Discrimination and calibration answer different questions. Discrimination concerns how well predictions distinguish among observed clinical outcomes, whereas calibration concerns whether predicted results correspond appropriately to what is observed. A model may therefore require examination from both perspectives, rather than relying on one summary measure, to judge its usefulness for diagnostic, prognostic, or treatment-support purposes.

Performance should be examined across disease prevalences because a model’s apparent usefulness may depend on the clinical population in which it is assessed. Comparing results across prevalence levels can reveal limits to generalizability and show whether conclusions from one setting transfer to another. This is especially important when evidence is intended for varied medical settings or patient groups.

Assessment across patient groups and clinical settings can detect uneven performance and possible bias. Rather than treating one overall result as sufficient, evaluators compare how the model behaves in different populations and environments. These comparisons help identify where evidence is limited and prevent broad claims of reliability when performance has only been examined in a narrow context.

A practical evaluation workflow begins by linking the model to its intended clinical purpose, then comparing predictions with observed outcomes using separate training and test data. Cross-validation can add another assessment during development. Evaluators then examine discrimination, calibration, sensitivity, specificity, and prediction error, followed by checks across patient groups, settings, and disease prevalences to assess generalizability.

Model evaluation supports several medical uses, including diagnostic models, prognostic models, and tools that support treatment decisions. The relevant question is not simply whether a model produces predictions, but whether those predictions show sufficient accuracy, reliability, and usefulness for the stated purpose. Results therefore inform whether a model offers dependable evidence for research or clinical decision-making.

Prediction error adds information that individual performance measures may not capture. Examining error alongside sensitivity and specificity, while also considering calibration and discrimination, gives a broader view of how predictions compare with observed outcomes. This combination helps investigators characterize strengths and limitations before using a model as evidence in medicine, where performance must remain relevant to its intended application.